The purpose of this study is to determine whether a blood test can help us make better decisions about who should get immunotherapy after surgery to remove the bladder for bladder cancer and which immunotherapy treatment is best.
Learn more about the A032103/MODERN trial or call the Cancer Research Office at Reading Hospital 484-628-8193.
